
Journal of Physical Chemistry p. 2505 - 2509 (1992)
Update date:2022-08-22
Topics:
Oxley, J. C.
Hiskey, M.
Naud, D.
Szekeres, R.
Kinetics and activation parameters of the solution thermolysis of nitramines dimethylnitramine, diisopropylnitramine, and N-nitropiperidine were determined over the temperature range 200-300 deg C.Each formed the corresponding nitrosamine as the only, or major, condensed-phase product.For dimethylnitramine the products were completely characterized.The observations of a large positive activation volume in the thermolysis of dimethylnitramine and of the slowing of the decomposition reaction with increased solvent viscosity both suggest that the rate-determining step is homolysis, the N-NO2 bond being the most obvious point for this.Nitrosamines could be produced by this route; however, when doubly 15N-labeled dimethylnitramine was heated with unlabeled dimethylnitramine, little scrambling of the label in the reactant was observed.Label scrambling was observed in the nitrosamine but could have resulted from subsequent N-NO homolysis.Scrambling of the label in the product gases and the observation of a kinetic isotope effect when perdeuterated dimethylnitramine was decomposed were explained in terms of a second decomposition route involving transfer of hydrogen from the α carbon to one of the NO2 oxygens.
View More
Zouping Mingxing Chemical Co.,Ltd.
website:http://www.zoutong.com.cn
Contact:86-543-2240068 2240067
Address:428 Daixi Third Road Zouping County Shandong Province China
Contact:+65 9658 0999
Address:26 Sin Ming Lane, Midview City, #05-118, Singapore 573971
Onlychem (Jinan)Biotech Co.,Ltd
Contact:86-531-83175885
Address:No. 44, Honglou South Road, Jinan,China
Contact:+86-25-83719363
Address:106-7 Chunnan Rd, Chunxi Town, Gaochun, Nanjing, China
Contact:Tel:+86-29-88764861 Fax:+86-29-88764861
Address:Rm#2107, Block A, Epin Meidao Building, Gaoxin Rd, Hi-Tech Zone, Xi’an, China
Doi:10.1002/ejic.202000790
(2021)Doi:10.1055/s-2005-918483
(2005)Doi:10.1016/S0022-328X(97)00757-2
(1998)Doi:10.1021/acs.molpharmaceut.9b00181
(2019)Doi:10.1039/b413132k
(2005)Doi:10.1038/138121a0
(1936)